Halma has announced that it has acquired two medtech firms for £54m, which will be bolted on to its healthcare companies, SSG and IZI Medical.

The life-saving technology firm has acquired the Dutch firm, itemedical, which provides digital platforms that integrate real-time patient data and alarms from different medical devices.

The £20m acquisition is set to enhance SSG’s digital capabilities and expands its offering in hospital workflow management, supporting growth in a market driven by increasing digitalisation in healthcare systems.

Halma has also acquired Naslund Medical for £34m, a Swedish company specialising in fiducual market technology used to support target cancer treatment.

Its core product, Gold Anchor, enables more precise targeting of tumours during radiation therapy.

The deal is expected to broaden IZI’s radiation oncology offering by adding Gold Anchor to its existing Visicoil platform, while also supporting IZI’s ambition to expand globally.

Following the announcement, shares in Halma increased by 1.2%.

Halma’s group chief executive, Marc Ronchetti, stated: "These acquisitions strengthen our existing companies by adding complementary capabilities in markets they know well, supporting their long-term growth while enabling improved patient outcomes.

"They operate in areas which have attractive long-term growth drivers and provide a strong platform for continued innovation and international expansion. We are pleased to welcome itemedical and Naslund Medical to Halma."

---